Sickle Cell Disease Treatment Centers Act of 2026
- Sponsor
- Rep. Adams, Alma S. [D-NC-12]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Sep 24, 2026
Bottom line
The bill aims to significantly improve access to comprehensive, coordinated, and lifelong care for individuals with sickle cell disease and other heritable hemoglobinopathies through a structured national network and enhanced public health surveillance.
What it actually does
This bill establishes a federal grant program to create Sickle Cell Disease Treatment Centers across the United States, utilizing a hub-and-spoke network model that integrates medical facilities with community-based organizations. It also mandates the creation of a National Sickle Cell Disease Coordinating Center and expands the Centers for Disease Control and Prevention's (CDC) data collection efforts for sickle cell disease and related conditions.
Proponents argue
Proponents argue that this legislation is crucial for addressing long-standing health disparities and improving the quality of life for individuals with sickle cell disease by ensuring access to specialized, integrated care, facilitating transitions from pediatric to adult care, and leveraging community support. They emphasize that the structured network and robust data collection will lead to better health outcomes and more effective public health strategies.
Opponents contend
No explicit opposition to the bill's core objectives of improving sickle cell disease care is identified. Potential concerns, if any, might revolve around the administrative complexity of establishing and overseeing a nationwide network, the fiscal implications of an open-ended appropriation authorization, or the balance between federal coordination and local autonomy in healthcare delivery.
The bill is moderately detailed but clearly structured, allowing an informed reader to understand its core provisions and implications within a reasonable timeframe.
Section 2, new Section 330Q(b)
Establishment of Sickle Cell Disease Treatment Centers Program
This provision directs the Secretary of Health and Human Services to award grants to eligible entities to establish 'Sickle Cell Disease Treatment Centers.' These centers are designed to use a 'hub-and-spoke' framework to provide coordinated, lifelong health care, improve patient well-being, facilitate pediatric-to-adult care transitions, collect clinical data, and conduct public health awareness activities for sickle cell disease.
Supporters argue
Supporters contend that establishing a dedicated, structured program is essential to address the fragmented and often inadequate care currently available to SCD patients, leading to better health outcomes and reduced health disparities.
Critics contend
No specific opposition is typically raised against establishing treatment centers for underserved conditions, though concerns might arise regarding funding priorities or administrative overhead.
Tradeoffs
The bill navigates the tension between the urgent need for comprehensive care for a vulnerable population and the administrative complexity and cost of establishing a nationwide, integrated healthcare network.
Section 2, new Section 330Q(a)
Definitions of Hub-and-Spoke Network, Medical Hub, and Spoke
This section defines the operational structure of the new treatment centers. A 'hub-and-spoke network' is a system where a 'medical hub' (a hospital, clinic, or university health center providing comprehensive SCD treatment) identifies and manages 'spokes' (other healthcare providers like FQHCs or primary care clinics) to deliver care, with both partnering with community-based organizations.
Section 2, new Section 330Q(d)
Detailed Use of Grant Funds by Eligible Entities
This provision specifies how grant funds must be used by the different components of an eligible entity. Medical hubs are required to cover operating costs, educate providers, provide integrated care (including mental health and genetic counseling), coordinate transitions, and collect data. Community-based organizations must provide education, outreach, support for social determinants of health, and testing. Spokes are mandated to collaborate with hubs, provide primary and specialty care, and collect data. Additional uses include securing reimbursement, assisting with insurance access, funding education programs, and developing social supports like transportation.
Section 2, new Section 330Q(f)
Establishment and Duties of National Sickle Cell Disease Coordinating Center
This provision mandates the Secretary of HHS to establish or contract for a National Sickle Cell Disease Coordinating Center. This center's duties include advising the Secretary on program design, developing a national strategy for equitable care, coordinating with federal agencies for data improvement, maintaining a comprehensive research and care strategy, establishing a rotating panel of stakeholders, and providing technical assistance to the hub-and-spoke frameworks.
Section 2, new Section 330Q(g)
Enhanced CDC Sickle Cell Disease Data Collection Program
This provision directs the CDC Director, in coordination with the National Coordinating Center, to expand and refine data collection, coordination, monitoring, and distribution related to SCD. This includes maintaining up-to-date data on SCD subtypes, health outcomes, and complications, improving national incidence/prevalence data, identifying health disparities, assessing therapy utilization, and evaluating risk factors. It also mandates the development of educational materials and public awareness campaigns regarding SCD and sickle cell trait.
Section 2, new Section 330Q(k)
Authorization of Appropriations and Allocation
This provision authorizes the appropriation of 'such sums as may be necessary' for fiscal year 2027 and each fiscal year thereafter to fund the entire program. It specifies how these appropriated funds are to be allocated: 70% for the activities of hub-and-spoke networks, 20% for community-based organizations, 5% for the National Sickle Cell Disease Coordinating Center, and 5% for the CDC's Sickle Cell Data Collection program.
Requires that a 'spoke' (a healthcare entity collaborating with a medical hub) must incorporate a community health worker into its care team to be considered an eligible part of the hub-and-spoke network.
Section 2, new Section 330Q(a)(4)(C)
Why it matters:This is likely standard legislative practice to define the characteristics of an entity that qualifies for the program. By placing it in the definition, it ensures that the model of care inherently includes this specific role from the outset, rather than being an optional add-on.
Case for: Supporters argue that mandating the inclusion of community health workers is crucial for addressing social determinants of health, improving patient engagement, and bridging gaps between clinical care and community resources, which is particularly vital for chronic conditions like SCD.
Case against: Some might argue that mandating a specific role could create staffing challenges or increase costs for smaller spoke entities, potentially limiting participation, especially in rural or underserved areas where such professionals might be scarce.
Estimated impact: This provision ensures that all funded 'spokes' will include community health workers, potentially increasing employment for these professionals and enhancing patient support services across the network, leading to more holistic patient care.